Literature DB >> 11469624

New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets.

T W Gardner1, D A Antonetti, A J Barber, K F LaNoue, M Nakamura.   

Abstract

Diabetic retinopathy, a leading cause of vision impairment, is classically defined by its vascular lesions. This review examines how diabetes affects vascular cells, as well as neurons, macroglia, and microglia. The cellular and clinical elements of diabetic retinopathy have many features of chronic inflammation. Understanding the individual cell-specific and global inflammatory changes in the retina may lead to novel therapeutic approaches to prevent vision loss.

Entities:  

Mesh:

Year:  2000        PMID: 11469624     DOI: 10.1089/15209150050502023

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  21 in total

Review 1.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

Review 2.  Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy.

Authors:  Juan-Juan Wang; Meili Zhu; Yun-Zheng Le
Journal:  World J Diabetes       Date:  2015-06-10

3.  Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes.

Authors:  Maulasri Bhatta; Jacey Hongjie Ma; Joshua J Wang; Jonna Sakowski; Sarah X Zhang
Journal:  Diabetologia       Date:  2015-06-11       Impact factor: 10.122

Review 4.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

5.  Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Authors:  J Cai; R Wei; X Ma; H Zhu; Y Li
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 6.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

7.  Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.

Authors:  Stephen M Cronk; Molly R Kelly-Goss; H Clifton Ray; Thomas A Mendel; Kyle L Hoehn; Anthony C Bruce; Bijan K Dey; Alexander M Guendel; Daniel N Tavakol; Ira M Herman; Shayn M Peirce; Paul A Yates
Journal:  Stem Cells Transl Med       Date:  2015-03-13       Impact factor: 6.940

8.  Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.

Authors:  Ramaprasad Talahalli; Simona Zarini; Nader Sheibani; Robert C Murphy; Rose A Gubitosi-Klug
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

9.  5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy.

Authors:  Rose A Gubitosi-Klug; Ramaprasad Talahalli; Yunpeng Du; Jerry L Nadler; Timothy S Kern
Journal:  Diabetes       Date:  2008-03-17       Impact factor: 9.461

10.  DKK1 inhibits proliferation and migration in human retinal pigment epithelial cells via the Wnt/β-catenin signaling pathway.

Authors:  Jinzi Zhou; Jian Jiang; Shuhong Wang; Xiaobo Xia
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.